Gene and Cell Therapies a Mass General Brigham System Wide Priority

GCT

In May the World Medical Innovation Forum featured panel discussions and content on cell and gene therapies across the sector. More than 20 hours of programming featured 150+ experts including clinical/scientific leaders, industry CEOs, venture investors, entrepreneurs, government decision makers and media. Topics covered

Videos of all Forum sessions are now available, including:

To see what nearly two dozen healthcare, scientific and investment experts say are the key issues and opportunities in gene and cell therapy read Accelerating the Future of Medicine with Gene and Cell Therapy: What Comes Next. The World Medical Innovation Forum and Recon Strategy teams prepared a description of what’s ahead for these potentially game-changing discoveries.

Also, be sure to Save the Date for next year’s Forum on gene and cell therapies in Boston on May 2-4, 2022.

Most Recent Posts:

Mass General Brigham AI and Digital Innovation Fund Invests in DexCare Series B – Technology offers data-driven management of access to care

DexCare, Inc., a data-driven intelligence company focused on healthcare access, today announced a $50M Series B funding…

Read More

Mass General Brigham and Bank of America Announce Partnership for World Medical Innovation Forum

2022 Event in Boston Features Biotech Breakthroughs in Gene and Cell Therapy BOSTON, MA – January 6,…

Read More

Enhanced IDF Submission via Insight Starts September 24

On Friday, September 24 an enhanced Invention Disclosure Form will be introduced via Insight. This new electronic…

Read More